Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463495) titled 'The Metabolic Effects of Oral Tributyrin Administration' on March 5. Study T... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463534) titled 'Atlas of Ultrasound Imaging of the Oral Cavity: Characterization and Descript... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07464028) titled 'Terazosin And Metabolic Energetics in Parkinson's Disease' on March 5. Study... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07461727) titled 'An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safet... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07461831) titled 'CD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cel... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462169) titled 'High Intensity Laser VS High Power Pain Threshold Ultrasound in Treatment of ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462221) titled 'Effect of Telenursing on Oral Health' on March 5. Study Type: Interventional... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462273) titled 'RISS Block for Enhanced Recovery After Video-Assisted Thoracoscopic Surgery' ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462325) titled 'Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462377) titled 'A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC' on March 5. Study... Read More